A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C

BACKGROUND: A randomized, double-blind, multinational, phase 3 study was conducted comparing the efficacy and safety of peginterferon lambda-1a (Lambda)/ribavirin (RBV)/telaprevir (TVR) vs. peginterferon alfa-2a (Alfa)/RBV/TVR in patients with chronic hepatitis C virus (HCV) genotype-1 (GT-1) infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Flisiak, Robert, Shiffman, Mitchell, Arenas, Juan, Cheinquer, Hugo, Nikitin, Igor, Dong, Yuping, Rana, Khurram, Srinivasan, Subasree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066958/
https://www.ncbi.nlm.nih.gov/pubmed/27749900
http://dx.doi.org/10.1371/journal.pone.0164563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066958/
https://www.ncbi.nlm.nih.gov/pubmed/27749900
http://dx.doi.org/10.1371/journal.pone.0164563

Ejemplares similares